ELDN

Eledon Pharmaceuticals Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↑ 7/10
  • Value↓ 4/10
Eledon Pharmaceuticals sales and earnings growth
ELDN Growth
Good
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 21.21%
  • FCF Y/Y↓ -31.88%
Eledon Pharmaceuticals gross and profit margin trends
ELDN Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -136.12%
Eledon Pharmaceuticals net debt vs free cash flow
ELDN Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Eledon Pharmaceuticals stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗